Science Behind Serlopitant

Serlopitant, a highly selective, once-daily, oral small molecule inhibitor of the neurokinin 1 receptor, or NK1-R, is an investigational drug that acts through a novel mechanism to potentially significantly alleviate pruritus and refractory chronic cough symptoms.

Pipeline of indications

Development programs at Menlo Therapeutics with Serlopitant